baber/WOPTO huggingface dataset:
Patent CA-2586933-A1 (CA)
Title: Ripper plough for soil tillage
Inventor: MCNABB DAVID H
IPC: A01B15/18
Filed: 2007-04-16
Abstract: A ripper plough for soil tillage includes a body having an upper mounting attachment end, a lower soil engaging end, leading edge, a trailing edge, opposed sides and a forward coulter along the leading edge between the upper mounting attachment end and the lower soil engaging end. A ploughshare support extends outwardly from the body from the leading edge toward the trailing edge at a plough angle of between 40 degrees and 55 degrees and extends outwardly and downwardly relative to the body at a thrust angle of between 40 degrees and 50 degrees. Ploughshares are mounted on the ploughshare support. The ploughshares have a length between a leading edge and a trailing edge of at least two feet and are spaced apart at the trailing edge by at least two feet, to provide an average lift angle of upward lift of between 10 degrees and 15 degrees.
Patent CA-2587431-A1 (CA)
Title: Procede de fabrication collective de microstructures a elements superposes
Inventor: ROMMEVEAUX PHILIPPE
IPC: H01L23/02
Filed: 2005-12-08
Abstract: L'invention concerne la fabrication collective de microstructures superposée s telles qu'un circuit intégré et un capot de protection. On fabrique collectivement des structures individuelles comportant chacune un premier élément et un second élément superposés ; les premiers éléments (exemple : puce de circuit intégré) sont préparés sur une première plaque (10) ; les deuxièmes éléments (exemple : capot transparent) sont préparés sur une deuxième plaque (40) ; les plaques sont collées l'une contre l'autre sur la majeure partie de leurs surfaces en regard, en excluant du collage des zones limitées (ZDn) où il n'y aura pas d'adhérence ; les structures individuelles sont ensuite découpées par le haut d'une part et par le bas d'autre part sel on des lignes de découpe parallèles différentes (LH1n, LH2n, LDn) passant dans les zones sans adhérence, de manière qu'après découpe les premiers éléments conservent des portions de surface (celles situées entre les lignes de décou pe parallèle) non recouvertes par un second élément ; un plot de connexion (PLn ) peut ainsi rester accessible à cet endroit. Application à la fabrication de capteurs d'image ou afficheurs, recouverts d'une plaquette de verre, mais pl us généralement aussi à toutes sortes de structures micro-usinées (MEMS, MOEMS) .
Patent CA-2587600-A1 (CA)
Inventor: RICHARDS ANDREW
IPC: H01B7/18
Filed: 2005-11-18
Abstract: A conductive slickline cable for use in oil wells is described which comprises a matrix material, preferably PEEK, a plurality of electrical conductors embedded in the maxtrix material with each electrical conductor being insulated by an imide. The cable has an outer protective coating of PEEK and an overall diameter less than 4mm, and preferably the same diameter as slickline cable, 3.175mm. The cable has a number of advantages being load bearing and being windable onto conventional slickline reels, as well as being offering electrical and power communication downhole.
Patent CA-2587652-A1 (CA)
Title: Cap with an angled spray channel for an aerosol container or a spray container
Inventor: EBERHARDT HEIKO
IPC: B65D83/14
Filed: 2005-11-21
Abstract: In order to achieve a comfortable level of spray noise using a cap (7) having a button (6) and an angled spray channel (10), it is suggested that the spray channel (10) be manufactured in one piece from elastic plastic, e.g., from TPE  or TPU.
Patent CA-2587802-A1 (CA)
Title: Preparation of borohydride salts
Inventor: TEICH CHERYL IRENE
IPC: C01B6/21
Filed: 2007-05-07
Abstract: A method for preparing a metal borohydride salt, M(BH4)n, where n is 1 or 2, from a slurry of sodium borohydride and a sodium alkoxide in a liquid hydrocarbon, wherein M is Li, K, Rb, Cs, Mg, Ca, Sr or Ba.
Patent CA-2589218-A1 (CA)
Inventor: PLATSCHER MICHAEL
IPC: C07C219/08
Filed: 2005-11-07
Abstract: La présente invention concerne du chlorure de DOTAP exempt d'énantiomères, ainsi que des modifications cristallines stables de chlorure de (2R,S)-, (2S)- et (2R)-DOTAP, un procédé pour produire ces modifications et leur utilisation comme composant pour fabriquer des médicaments.
Patent CA-2589608-A1 (CA)
Inventor: PARSONS JOHN
IPC: B32B38/14
Filed: 2007-05-18
Abstract: Wallcoverings which include a nonwoven synthetic substrate and a water--based ground coating which is applied thereto. The ground coating includes emulsion polymer pigment binders and a mineral pigment composition. The ground coating provides the nonwoven substrate with superior printing and durability properties, enabling the production of wallcoverings which may be printed with a decorative design. The wallcoverings are desirable for environmental, health, and safety reasons.
Patent CA-2591192-A1 (CA)
Inventor: KIMURA SUMI
IPC: C11D1/72
Filed: 2005-12-28
Abstract: Disclosed is an oil solution for dust adsorption which contains a base oil (A), a nonionic surfactant (B) and an allergen-inactivating component (C).  Such an oil solution for dust adsorption can be preferably used for cleaning/wiping tolls such as mops and wipers which have a dry fibrous base.
Patent CA-2591756-A1 (CA)
Inventor: HERSCH ROGER D
IPC: G07D7/12
Filed: 2005-06-23
Abstract: L'invention concerne un modèle de disposition d'image de moiré à bandes pouvant prédire la disposition d'une couche d'image de moiré à bandes obtenue lorsqu'une couche de réseau à bandes de base présentant une certaine disposition est superposée avec une couche de réseau de lignes d'apparition présentant une certaine disposition. Les couches de réseau à bandes de base et de réseau de lignes d'apparition peuvent présenter une disposition rectiligne ou curviligne. La disposition de l'image de moiré à bandes obtenue peut également être rectiligne ou curviligne. Le modèle de disposition de l'image de moiré à bandes permet de pouvoir sélectionner la disposition de deux couches sélectionnées dans le groupe comprenant : couche de réseau à bandes de base, couche de réseau de lignes d'apparition et couche d'image de moiré à bandes ; et d'obtenir la disposition de la troisième couche par calcul, à savoir automatiquement. Un système de calcul peut générer automatiquement, sur demande, un document de sécurité protégé individuel présentant des dispositions de réseau à bandes de base et de réseau de lignes d'apparition spécifiques.
Patent CA-2592573-A1 (CA)
Title: Multi-route administration of immune response modifier compounds
Inventor: GUY CYNTHIA A
IPC: A61K39/385
Filed: 2005-12-28
Abstract: A method of treating disease with immune response modifier (IRM) compounds by using at least two different routes of administration, such as administering at least one IRM to a subject locally (e.g., topically) at a disease site in combination with separately administering at least one IRM to the subject systemically (e.g., orally or by injection).
Patent CA-2595884-A1 (CA)
Inventor: JOHNSON MARK
IPC: B62B5/00
Filed: 2007-07-31
Abstract: A children's wagon includes a body supported by wheels and having an interior. Panels are pivotally attached to the wagon body and are positioned within the interior of the wagon. At least one such panel has a second panel pivotally attached to it. The panels may be moved between generally upright and horizontal positions so that the wagon features multiple interior configurations.
Patent CA-2600016-A1 (CA)
Inventor: ADAM JOHN DOUGLAS
IPC: H01L29/423
Filed: 2006-03-02
Abstract: Un transistor résonnant comprend un substrat, une source et un drain formé sur le substrat, une électrode d'entrée et une porte en nanotube de carbone. Un espace est formé entre la source et le drain. L'électrode d'entrée est formée sur le substrat, la porte en nanotube de carbone est fixée sur une extrémité par une électrode de contact et positionnée, de préférence en porte-à-faux, au-dessus de l'espace et au-dessus de l'électrode d'entrée.
Patent CA-2600195-A1 (CA)
Title: Combinations for the treatment of cancer
Inventor: CHANG DAVID
IPC: A61K39/395
Filed: 2006-03-22
Abstract: This invention is in the field of pharmaceutical agents and specifically relates to compounds, compositions, uses and methods for treating cancer.
Patent CA-2600250-A1 (CA)
Inventor: FONG COLIN
IPC: G07F17/32
Filed: 2007-09-06
Abstract: Disclosed is gaming apparatus, which may be a gaming system (200) and a method of gaming implemented on gaming apparatus. A plurality of linked gaming machines (100) are monitored for the occurrence of a first event. The number of occurrences of the first event for each gaming machine (100) is recorded. On the occurrence of a second event, a bonus is awarded on each said gaming machine (100) on which at least one monitored occurrence of the first event has occurred, the bonus award being dependent on the number of occurrences of the first event.
Patent CA-2600568-A1 (CA)
Title: Prophylactic/therapeutic agent for cancer
Inventor: SATOU SHUJI
IPC: C12N15/09
Filed: 2006-03-14
Abstract: An agent which acts on a molecule expressed specifically in cancer cells, which can induce the inhibition of the growth of cancer cells, and which is safe. More specifically, a neutralizing antibody directed against a protein having an amino acid sequence identical or substantially identical to the amino acid sequence depicted in SEQ ID NO:1, 3, 5, 7 or 9 or a partial peptide of the protein or a salt of the protein or partial peptide; and a prophylactic/therapeutic agent for cancer (e.g., breast, ovarian, colorectal, lung or pancreatic cancer), an apoptosis enhancer, a growth inhibitor for cancer cells, an antagonist of DDR1 or the like comprising the neutralizing antibody.
Patent CA-2603129-A1 (CA)
Title: Crystalline forms of pregabalin
Inventor: LEVI SIGALIT
IPC: C07C229/08
Filed: 2006-04-06
Abstract: Crystalline form of Pregabalin characterized by X-ray powder diffraction peaks at about 5.8, 18.4, 19.2, 20.7, and 23.7~ 2.theta. ~ 0.2~ 2.theta., methods for its preparation, its pharmaceutical compositions thereof, and methods for the preparation of crystalline form of Pregabalin characterized by X-ray powder diffraction peaks at about 5.7, 15.4, 17.2, 18.2, and 23.0~ 2.theta. ~  0.2~ 2.theta., are provided.
Patent CA-2604846-A1 (CA)
Inventor: HERZ UDO
IPC: A61K35/745
Filed: 2006-03-22
Abstract: The present invention is directed to a novel use of LGG in the manufacture of a medicament for the prevention or treatment of respiratory allergies in a subject.
Patent CA-2606004-A1 (CA)
Title: Dipiperazinyl ketones and related analogues
Inventor: GE PING
IPC: A61K31/551
Filed: 2006-07-28
Abstract: Dipiperazinyl ketones and related analogues are provided, as are methods for their preparation and use. Such compounds may generally be used to modulate ligand binding to histamine H3 receptors in vivo or in vitro, and are particularly useful in the treatment of a variety of disorders in humans, domesticated companion animals and livestock animals. Pharmaceutical compositions and therapeutic methods are provided, as are methods for using such ligands for detecting histamine H3 receptors (e.g., receptor localization studies).
Patent CA-2608426-A1 (CA)
Inventor: BENNI PAUL B
IPC: A61B5/00
Filed: 2006-05-10
Abstract: According to the present invention, a method and apparatus for non-invasively determining the blood oxygen saturation level within a subject's tissue is provided. The method comprises the steps of: 1) providing a near infrared spectrophotometric sensor operable to transmit light along a plurality of wavelengths into the subject's tissue; 2) sensing the light transmitted into the subject's tissue using the sensor, and producing signal data representative of the light sensed from the subject's tissue; 3) processing the signal data to account for physical characteristics of the subject; and 4) determining the blood oxygen saturation level within the subject's tissue using a difference in attenuation between the wavelengths. The apparatus includes a sensor having a light source and at least one light detector, which sensor is operably connected to a processor. The sensor is operable to transmit light along a plurality of wavelengths into the subject's tissue, and produce signal data representative of the light sensed from the subject's tissue. The algorithm is operable to process the signal data to account for the physical characteristics of the subject being sensed.
Patent CA-2609259-A1 (CA)
Title: Discrete patch for viral lesions
Inventor: HART WILLIAM
IPC: A61F13/00
Filed: 2006-05-25
Abstract: The invention is a discrete patch suitable for use in the treatment of a viral lesion, which patch includes a backing layer and an adhesive layer, where the adhesive layer is substantially free of hydrocolloid particles, and the patch has a thickness ranging from about 10 microns to about 1,500 microns and is substantially free of topical anti-acne agents, and methods for treating viral lesions where a discrete patch of the invention is applied to a viral lesion and maintained in contact therewith for a time effective to substantially complete re-epithelialization of the lesion.
Patent CA-2612980-A1 (CA)
Inventor: BIEMANS RALPH LEON
IPC: A61K39/116
Filed: 2006-06-23
Abstract: The present application discloses an immunogenic composition comprising a Hib saccharide conjugate and at least two further bacterial saccharide conjugates wherein the Hib conjugate is present in a lower saccharide dose than the mean saccharide dose of all the at least two further bacterial saccharide conjugates.
Patent CA-2613680-A1 (CA)
Inventor: STUHR VICTOR K
IPC: B64C23/06
Filed: 2006-06-26
Abstract: Methods and systems for efficiently increasing the wing area of an aircraft are disclosed herein. An integrated wingtip extension (310) configured in accordance with one embodiment of the invention includes a tapered wing section and a winglet (304). The tapered wing section (308) includes an inboard end portion (306) having a first chord length (L1) and an outboard end portion (306) having a second chord length (L2) that is less than the first chord length (L1). The winglet (304) is fixedly attached to the outboard end portion (3016). The inboard end portion (306) is configured to be fixedly attached to a tip portion of an aircraft wing (302). In one embodiment, the tapered wing section (308) and the winglet (304) can be integrally formed from composite materials.
Patent CA-2614214-A1 (CA)
Inventor: WEGMANN THOMAS
IPC: C05G3/60
Filed: 2006-06-27
Abstract: Disclosed are herbicidal agents containing A) a compound from the group comprising benzoylpyrazoles, B) at least one additional herbicide, and C) at least one safener, as herbicides that are effective against monocotyledonous and/or dicotyledonous weeds. Said agents are provided with an effect that is superior to the effect of the herbicides used individually while featuring a high degree of cultigen compatibility.
Patent CA-2617341-A1 (CA)
Inventor: LOWERY DAVID EARL
IPC: A61K39/00
Filed: 2006-07-17
Abstract: The present invention relates to a vaccine for immunizing a cat against feline viruses. The present invention also relates to a nucleic acid clone that encodes the capsid protein of the isolated feline calicivirus. The present invention further relates to a live or killed vaccine comprising the isolated feline calicivirus, a subunit vaccine comprising the capsid protein of the isolated feline calicivirus, a nucleic acid vaccine comprising a nucleic acid clone of the isolated feline calicivirus, and a recombinant virus vector vaccine comprising nucleic acid encoding the capsid protein of the isolated feline calicivirus. The present invention also relates to a method for identifying a feline calicivirus useful for producing a vaccine composition and for assays for diagnosing cats infected with feline calicivirus. Also disclosed is a method of immunizing animals, especially cats, against disease, in particular against feline calicivirus (FCV). The method includes administering to a cat therapeutically effective amounts of first and second FCV vaccines. The first vaccine is administered orally or parenterally (e.g., subcutaneously, intramuscularly, and the like). The second vaccine is administered orally or oronasally N days following administration of the first vaccine, wherein N is an integer from 3 to 120, inclusive. A third vaccine administration may also be given. The present invention also describes methods and materials for treating and immunizing animals with vaccine, and in particular cats against both FPV or Feline Parvovirus, which has also been called Panleukopenia or FPL and against another disease, FHV or Feline Herpes Virus, which has also been called Feline Rhinotracheitis Virus.
Patent CA-2619566-A1 (CA)
Title: 6-substituted-2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
Inventor: POKROVSKAIA NATALIA
IPC: A61P25/00
Filed: 2006-09-01
Abstract: The present invention provides 6-substituted 2,3,4,5-tetrahydro-lH-benzo[d]azepines of Formula (I) as selective 5-HT2C receptor agonists for the treatment of 5-HT2c associated disorders including obesity, obsessive/compulsive disorder, depression, and anxiety: R6 D R N-R" R* where R6 is -(CrC3)alkyl-S-(C0-C3)alkyl-R10, -(C1-C3)alkyl-NR11R12, -(CrC3)alkyl-O-R 13. and other substituents are as defined in the specification.
Patent CA-2621879-A1 (CA)
Inventor: EMMITTE KYLE ALLEN
IPC: A61P35/00
Filed: 2006-08-28
Abstract: The present invention provides benzimidazole thiophene compounds pharmaceutical compositions containing the same, processes for preparing the same and their use as pharmaceutical agents (formulaes A to H).
Patent CA-2622904-A1 (CA)
Title: Self-assembling nanoparticles for the treatment of vascular diseases
Inventor: HELMUS MICHAEL N
IPC: A61P43/00
Filed: 2006-08-25
Abstract: The present invention is directed to the formation of structures in situ through the principles of ligand binding. These structures are efficacious, for example, for tissue repair as well as for short- and long-term disease and condition management. According to one aspect of the invention, an injectable composition comprising self-assembling nanoparticles is provided. The self-assembling nanoparticles include: (a) a nanoparticle portion, (b) tissue binding ligands attached to the nanoparticle portion, which cause preferential binding and accumulation of the nanoparticles at one or more targeted tissue locations upon injection of the composition into the body, and (c) first and second interparticle binding ligands attached to the nanoparticle portion, which cause interparticle binding upon injection of the composition into the body.
Patent CA-2624330-A1 (CA)
Title: Method and apparatus to prevent or minimize the entrapment of passengers in elevators during a power failure
Inventor: PETERS RICHARD D
IPC: B66B1/06
Filed: 2006-10-05
Abstract: The invention provides a system and method for handling power outages in a multiple car elevator system in a building having a plurality of floors. The system includes an energy calculator connected to the elevators, and determines a total energy of the elevator system, a total energy required to handle a power outage, a plan to prepare for a power outage and a plan to handle a power outage. The system also includes a movement controller connected to the elevator(s) and the energy calculator. The movement controller receives the plan to prepare and the plan to handle from the energy calculator, and the movement controller executes the plan to prepare if there is no power outage and the movement controller executes the plan to handle if there is a power outage.
Patent CA-2626877-A1 (CA)
Title: Concasseur et procede de commande de ce concasseur
Inventor: LEHTONEN HARRI
IPC: B02C25/00
Filed: 2005-11-02
Abstract: Concasseur et procédé de commande de ce concasseur (11) qui comprend un premier élément broyeur (5) et un second élément broyeur (6) définissant le réglage de concasseur (S) d'une cavité de broyage (7) dans laquelle on alimente le matériau à concasser. Le procédé comprend les étapes consistant à : mesurer en continu la charge instantanée sur le concasseur ; enregistrer les pointes de charge instantanée dépassant un niveau cible prédéterminé pour les pointes de charge ; suivre le nombre de pointes de charge dépassant le niveau cible prédéterminé pendant une période predetermine ; et commander le chargement du concasseur en fonction du nombre de pointes de charge subi par le concasseur pendant la période prédéterminée.
Patent CA-2627195-A1 (CA)
Title: Method and system for virtualized health monitoring of resources
Inventor: PAUL CHAKKALAMATTAM JOS
IPC: G06F11/34
Filed: 2006-10-16
Abstract: A method and system for monitoring computational resources within a data processing system is presented. A monitoring service receives a non-application-specif ic request to perform a monitoring operation in order to gather information about the usage of a computational resource within a data processing system. The monitoring service automatically selects a monitoring application from a set of monitoring applications in which the selected monitoring application is are able to perform the monitoring operation on the computational resource. The monitoring service then sends to the selected monitoring application an application-specific request that identifies the computational resource and indicates the monitoring operation to be performed on the computational resource.
Patent CA-2627366-A1 (CA)
Title: Glass compositions
Inventor: LEWIS ALBERT
IPC: C03C13/06
Filed: 2006-10-23
Abstract: Improved glass fibers compositions, typically useful for fire resistant blankets or containers to provide high burn-through resistance at high temperatures of 2,400~F and higher, and typically comprising silica, sodium oxide, potassium oxide, calcium oxide, magnesium oxide, f errous+f erric oxide, and titanium oxide; the improved glass compositions may further include alumina, lithium oxide, and boron oxide.
Patent CA-2629714-A1 (CA)
Title: Administration of an mtor inhibitor to treat patients with cancer
Inventor: BEDROSIAN CAMILLE L
IPC: A61K31/436
Filed: 2006-11-14
Abstract: The invention features methods for treatment of a patient in need thereof with the administration of mammalian target of rapamycin (mTOR) inhibitors such as sirolimus, temsirolimus, everolimus or rapamycin analogs including AP23573, especially to a cancer patient for 4 or 5 consecutive days per week. The mTOR  inhibitor therapy can be used for a wide range of cancers including prostrate, pancreas, ovary, lung, breast, bladder, colon, brain, head and neck, endometrium, leukemia, lymphoma and sarcoma.
Patent CA-2629936-A1 (CA)
Title: Biocompatible surgical compositions
Inventor: BELCHEVA NADYA
IPC: C08G18/00
Filed: 2006-12-08
Abstract: Biocompatible compositions are provided including a first polymer component including an isocyanate-functional polyalkylene oxide combined with at least one multi-isocyanate functional polyether-polyurethane, and a second component including at least one diamine.
Patent CA-2632517-A1 (CA)
Inventor: VIDUGIRIENE JOLANTA
IPC: C07K16/00
Filed: 2006-12-06
Abstract: The present invention relates in general to cellular analysis tools and more particularly to methods of determining cyclic nucleotide concentrations in samples.